Related Experiment Video
Updated: Jul 5, 2026

Cecal Ligation Puncture Procedure
Published on: May 7, 2011
Cytokine production and outcome in MDR versus non-MDR gram-negative bacteraemia and sepsis
Vasileios Karamouzos1, Evangelos J Giamarellos-Bourboulis2, Dimitrios Velissaris3
1Intensive Care Unit, University Hospital of Patras, Patras, Greece.
Background:
Sepsis represents a life-threatening syndrome characterized by a cytokine storm. Whether cytokine levels are related to the susceptibility pattern of invasive micro-organism remains a matter of debate. The purpose of this study is to investigate the immune response in multidrug resistant (MDR) and non-MDR sepsis patients by measuring cytokine levels, compare the outcome and determine predictors of mortality.
Materials And Methods:
A total of 128 septic patients, treated in intensive care unit (ICU) were enrolled in the study. Epidemiological and ICU data were recorded. Plasma concentrations of angiopoietin-2 (Ang-2), interleukin (IL)-6, IL-10, tumour necrosis factor-α (TNF-α) and soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) were measured on admission.
Results:
A total of 90 patients suffered from non-MDR and 38 from MDR gram-negative sepsis. Levels of TNF-α were significantly higher (p = .017) in non-MDR sepsis patients. All pro-inflammatory cytokines were significantly increased in severely ill patients compared to patients with lower acute physiology and chronic health evaluation (APACHE) II score. MDR positive patients had a significantly lower 28-d survival (p = .008). Factors that were independently associated with higher 28-d mortality were carbapenem resistance (OR 5.38 [1.032 - 28.12], p = .046), male gender (OR 2.76 [1.156 - 6.588], p = .022), APACHE II score (OR 1.126 [1.048 - 1.21], p = .001) and Ang-2 (OR 1.025 [1.001 - 20.1], p = .048).
Conclusions:
Sepsis evolution and outcome are influenced by multiple factors. Although MDR pathogens induced a weaker immune response characterized by lower TNF-α levels this was not accompanied by better survival. Increased Ang-2 levels, APACHE II score and carbapenem resistance are important factors associated with higher mortality.
Insights
Multidrug-resistant sepsis patients show a weaker immune response but poorer survival. Carbapenem resistance, male gender, APACHE II score, and angiopoietin-2 levels predict mortality in sepsis.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Immunology
Background:
- Sepsis is a life-threatening condition involving a cytokine storm.
- The relationship between cytokine levels and pathogen susceptibility in sepsis is debated.
- Understanding immune response variations in multidrug-resistant (MDR) sepsis is crucial.
Purpose of the Study:
- To investigate immune responses in MDR and non-MDR sepsis patients by measuring cytokine levels.
- To compare patient outcomes based on MDR status.
- To identify predictors of mortality in sepsis patients.
Main Methods:
- 128 sepsis patients in the ICU were enrolled.
- Plasma levels of angiopoietin-2 (Ang-2), IL-6, IL-10, TNF-α, and sTREM-1 were measured.
- Epidemiological and ICU data, including APACHE II scores, were collected.
Main Results:
- Tumor necrosis factor-α (TNF-α) levels were higher in non-MDR sepsis patients (p=0.017).
- Pro-inflammatory cytokines increased with higher APACHE II scores.
- Multidrug-resistant (MDR) sepsis patients had significantly lower 28-day survival (p=0.008).
- Predictors of mortality included carbapenem resistance (OR 5.38), male gender (OR 2.76), APACHE II score (OR 1.126), and Ang-2 (OR 1.025).
Conclusions:
- Multidrug-resistant (MDR) pathogens may elicit a weaker immune response (lower TNF-α) but do not improve survival.
- Increased angiopoietin-2 (Ang-2) levels, higher APACHE II scores, and carbapenem resistance are significant predictors of mortality in sepsis.
- Sepsis outcomes are multifactorial, influenced by pathogen resistance and host immune response.
Related Concept Videos
Bacterial Meningitis
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology

